CELLECTAR BIOSCIENCES INC CLRB
ASignal's systematic analysis rates CLRB as Bearish.
Reflects the latest available analysis · analyzed Nov 10, 2026
The case on CLRB
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $33.99M in cash versus $1.53M in total debt
- Low debt-to-equity ratio of 0.05x indicating minimal leverage
- High current and quick ratios (6.66x and 6.49x) suggesting strong short-term liquidity
- EV/EBITDA of 0.87x indicates potential undervaluation relative to earnings before adjustments
- Negative return on equity (-119.57%) and return on assets (-58.44%) signaling severe profitability issues
- Negative free cash flow of $-12.52M and operating cash flow of $-19.48M
- Forward P/E of -0.63x and lack of revenue/earnings growth data suggest unprofitable outlook
- Price trading below 20-day and 50-day moving averages (SMA20: 1.214, SMA50: 1.703)
- MACD below signal line with negative momentum trend
See the full verdict on CLRB
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CLRB
Most investors never get a second opinion, let alone several. ASignal runs CLRB past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.